NCT00832169View on ClinicalTrials.gov

Investigation of Rate+Extent of Excretion of Radioactivity in Urine+Faeces After Oral Administration of [14C]AZD1386

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

January 31, 2009

Study Completion Date

February 28, 2009

Conditions

Pain

Interventions

DRUG

AZD1386

1 dose of oral solution

Trial Locations (1)

Unknown

Research Site, Macclesfield

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY